Ajax-Loading

Novartis AG - Debt To Equity Ratio

Novartis AG's Fiscal Year is From January To December.

The item "Debt-To-Equity-Ratio" stands at 0.6854 as of 09/30/2025.

As of the end of Novartis AG's third quarter, the item "Debt To Equity Ratio" stands at 0.6854. This represents a decrease of -7.31 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -2.86 percent compared to the value the year prior.
The 1 year change in percent is -2.86.
The 3 year change in percent is 54.18.

The Serie's long term average value is 0.595. It's latest available value, on 09/30/2025, is 15.17 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2022, to it's latest available value, on 09/30/2025, is +54.22%.
The Serie's change in percent from it's maximum value, on 03/31/2025, to it's latest available value, on 09/30/2025, is -11.49%.

Debt To Equity Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Debt To Equity Ratio905,699,262,464.00
LogoJohnson & Johnson - Debt To Equity Ratio486,508,953,600.00
LogoAbbVie Inc - Debt To Equity Ratio399,570,305,024.00
LogoRoche Holding AG - Debt To Equity Ratio317,433,206,677.55
LogoAstraZeneca PLC - Debt To Equity Ratio280,205,508,085.11